Dr. Adnan Ahmad Ansari

Designation: Assistant Professor
Email Address: This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
Office Phone:  +92-051 9064-4177

Postdoc: Gachon Institute of Genome Medicine and Science Gachon University, South Korea 

PhD: University of Ulsan, South Korea

Other Links:  Research Gate: https://www.researchgate.net/profile/Adnan-Ansari-3;

Google Scholar https://scholar.google.com/citations?user=Wd_PGSEAAAAJ&hl=en

Office: National Centre for BioInformatics, Quaid-i-Azam University, Islamabad 

Other Links: HEC | Personal Page

 

Postdoc: Gachon Institute of Genome Medicine and Science Gachon University, South Korea 
PhD: University of Ulsan, South Korea
Other Links:  Research Gate: https://www.researchgate.net/profile/Adnan-Ansari-3; 
Google Scholar https://scholar.google.com/citations?user=Wd_PGSEAAAAJ&hl=en 

My research interest lies in the characterization of different cancer sub-types on the basis of their genomic profiles. This will help us in understanding the molecular basis of cancer more effectively and thus, it will further assist in treating the patients more efficiently. In recent years, our understanding of cancer increased tremendously and a series of biomarkers have been developed to assist personalized treatment of cancer. Unfortunately, still more than 60% of cancer patients don’t have any known biomarker or signature that may help us in treating them more effectively. This is one of the major reasons that we are still unable to achieve the goal of increasing overall survival rate in cancer patients significantly.

 

Publications

  1. Khan, A., Shin, J.-Y., So, M.K., Na, J.-H., Justesen, S., Ansari, A.A., Ko, B.J., and Ahn, S.-M. (2021) Characterization of HLA-A*33:03 epitopes via immunoprecipitation and LC-MS/MS. PROTEOMICS, 2100171.

  2. Park, I.J., Yu, Y.S., Mustafa, B., Park, J.Y., Seo, Y.B., Kim, G.-D., Kim, J., Kim, C.M., Noh, H.D., Hong, S.-M., et al. (2020). A Nine-Gene Signature for Predicting the Response to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer. Cancers 12, 800.

  3. Shoaib, M.*, Ansari, A.A.*, Haq, F., and Ahn, S.M. (2019). IPCT: Integrated Pharmacogenomic Platform of Human Cancer Cell Lines and Tissues. Genes 10, 171. (Co-first author)

  4. Ansari, A.A., Park, I., Kim, I., Park, S., Ahn, S.-M., and Lee, J. (2018). Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer. BMC Medical Genomics 11, 88.

  5. Shoaib, M., Ansari, A.A., and Ahn, S.-M. (2017). cMapper: gene-centric connectivity mapper for EBI-RDF platform. Bioinformatics 33, 266–271.

  6. Ahn, S.-M.*, Ansari, A.A.*, Kim, J., Kim, D., Chun, S.-M., Kim, J., Kim, T.W., Park, I., Yu, C.-S., and Jang, S.J. (2016). The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy. Oncotarget 7, 68638–68649. (Co-first author)

  7. Bang, S.-Y., Na, Y.-J., Kim, K., Joo, Y.B., Park, Y., Lee, J., Lee, S.-Y., Ansari, A.A., Jung, J., Rhee, H., et al. (2014). Targeted exon sequencing fails to identify rare coding variants with large effect in rheumatoid arthritis. Arthritis Res. Ther. 16, 447.

  8. Ahn, S.-M., Jang, S.J., Shim, J.H., Kim, D., Hong, S.-M., Sung, C.O., Baek, D., Haq, F., Ansari, A.A., Lee, S.Y., et al. (2014). Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification. Hepatology 60, 1972–1982.
 
 
 
 

 

 

 


Facebook